Finally, SAA patients have been shown to carry somatic mutations similar to those mutated in MDS (i.e., ASXL1, DNMT3A, TET2, and others), indicating transformation into secondary MDS (82, 130). This evidence concerns the gene ASXL1 and myelodysplastic syndrome.